Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions

Diagnosis and management of α1-antitrypsin deficiency

M. Luisetti
Breathe 2007 4: 38-46; DOI:
M. Luisetti
Institute for Respiratory Disease, Fondazione IRCCS Policlinico, San Matteo, University of Pavia, Viale Golgi 16, 27100 Pavia, Italy. Fax: . E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: m.luisetti@smatteo.pv.it
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Educational aims

  1. To increase awareness of α1-antitrypsin (AAT) deficiency and to describe the characteristics of this relatively common inherited disorder that can lead to lung disease.

  2. To describe methods of patient identification and diagnosis of AAT deficiency.

  3. To familiarise the reader with management and treatment options available to AAT-deficient patients.

  4. To explain the role of the respiratory professional in the diagnosis and management of AAT-deficient patients.

Summary α1-Antitrypsin (AAT) deficiency is a genetic disorder characterised by a low serum level of AAT, which predisposes individuals to early-onset pulmonary disease, most commonly emphysema. Although it is one of the most common inherited conditions leading to lung disease, AAT deficiency is an under-recognised condition. It is believed that only ∼5% of AAT-deficient individuals have been diagnosed and the vast majority are therefore unaware that they could benefit from lifestyle changes to reduce morbidity (such as smoking cessation), or from the specific therapy that is available. This review describes the role of respiratory professionals in identifying, diagnosing and managing AAT-deficient patients and outlines the therapeutic options available.

  • ©ERS 2007
PreviousNext
Back to top
Vol 4 Issue 1 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Diagnosis and management of α1-antitrypsin deficiency
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Diagnosis and management of α1-antitrypsin deficiency
M. Luisetti
Breathe Sep 2007, 4 (1) 38-46;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Diagnosis and management of α1-antitrypsin deficiency
M. Luisetti
Breathe Sep 2007, 4 (1) 38-46;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Info & Metrics
  • PDF

Subjects

  • Epidemiology, occupational and environmental lung disease
  • Pulmonary pharmacology and therapeutics
  • Respiratory clinical practice
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • A clinicians’ review of the respiratory microbiome
  • The problems of cohort studies
  • Breathing exercises for asthma
Show more Review

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About Breathe

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Intructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 1810-6838
Online ISSN: 2073-4735

Copyright © 2023 by the European Respiratory Society